AMBER WALLS: Open Payments
NPI 1548632524 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 116 payments from 28 companies in 2025. Trend: 2023 $2,495 · 2024 $2,693 · 2025 $2,455
Food & beverage: $2,455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $277 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $256 |
| PFIZER INC. | 11 | $249 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $245 |
| Lilly USA, LLC | 13 | $241 |
| AstraZeneca Pharmaceuticals LP | 13 | $223 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| ABBVIE INC. | 4 | $75 |
| Gilead Sciences, Inc. | 3 | $72 |
| Abbott Laboratories | 3 | $70 |
Products named: JARDIANCE, Kerendia, Wegovy, MOUNJARO, ELIQUIS, AIRSUPRA, PREVNAR 20, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
